Project Grant P30GM165332
- The National Institute of General Medical Sciences awarded the University of North Dakota $112,084 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to study mentorship structures that shape biomedical researcher career trajectories and long-term persistence in independent research. The recipient will integrate longitudinal dissertation records, publication data, and collaboration histories to reconstruct advisor-student relationships spanning...
- The National Institute of General Medical Sciences awarded the Board of Regents of the University of Nebraska $1,173,748 on July 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support Phase 3 of the Nebraska Center for Integrated Biomolecular Communication (NCIBC). NCIBC advances understanding of biomolecular communication pathways that regulate cellular functions and coordinate intercellular actions, with application to disease mechanisms and targeted...
- Federal Project Grant Award Summary North Dakota State University received a $283,250 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 19, 2025, with a completion date of July 31, 2027. The award supports biomedical research to investigate junctophilin-2 (JPH2) as a novel regulator of antiviral innate immune response in cardiomyocytes. The research addresses two primary...
- The National Institute of General Medical Sciences awarded Montana State University $4.288 million on April 15, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to establish the Center for Advanced Molecular Pathogenesis (CAMP), a Phase 1 Center of Biomedical Research Excellence focused on recruiting, developing, and retaining investigators who translate discoveries in pathogenesis into treatments, vaccines, and cures. The center leverages existing infrastructure...
- The National Institute of Allergy and Infectious Diseases awarded the University of Notre Dame DU Lac $709,532 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct systematic research into the cytoplasmic pathway for peptidoglycan recycling in Pseudomonas aeruginosa, an antibiotic-resistant gram-negative bacterial pathogen responsible for recurrent lung infections in cystic fibrosis patients. The work addresses two specific aims. The first...
- The National Science Foundation Division of Molecular and Cellular Biosciences awarded North Dakota State University $570,477 on July 1, 2026, under the Biological Sciences program (CFDA 47.074) for a CAREER award investigating electrically encoded innate immune sensing in cardiomyocytes. The project addresses how electrically active heart cells detect and respond to foreign or misplaced genetic material—such as viral DNA or RNA—through electrical signaling. The research combines patch-clamp...
- Federal Grant Award Summary The University of New Mexico Health Sciences Center received a $2,094,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2029. This research project investigates the intersection between the methionine cycle and coronavirus RNA capping mechanisms, with the primary objective of identifying novel drug targets to inhibit...
- The National Institutes of Health Office of the Director awarded the University of Minnesota Duluth a $1,369,144 cooperative agreement on March 16, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to establish the Biomedical Research Environment–Scholarly Professional Development and Administrative Enhancement (BRE-SPAD) project. The award funds a cross-institutional collaboration between the University of Minnesota Duluth and Fond du Lac Tribal & Community...
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of North Dakota $192,065 on August 15, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a dual-immersion bidirectional light sheet microscopy platform for volumetric imaging across intestinal tissue layers. The project addresses limitations in current imaging tools for capturing dynamic cellular processes in intact...
- The National Institute of General Medical Sciences awarded the University of Notre Dame $632,000 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859, Assistance Listing R35GM161777) to support investigation of cellular mechanisms affecting protein folding and the production of a functional proteome. The recipient will conduct experimental and computational research integrating biophysics, molecular biology, and related disciplines to study how the cellular...
The National Institute of General Medical Sciences awarded the University of North Dakota $1,057,500 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to sustain research in host-pathogen interactions at its Center for Excellence in Host Pathogen Interactions. The award funds the third phase of a Centers of Biomedical Research Excellence (COBRE) initiative to maintain and advance the host-pathogen interactions research program through four operational cores supporting state-of-the-art imaging, histology, flow cytometry, and computational approaches. The funding supports core operations enabling cutting-edge research, transition to financial sustainability, and researcher training and educational workshops. The award also supports a pilot project program to promote high-quality research and cross-disciplinary collaboration, and funds expansion of the research group's reach through partnerships with other IDEA State groups and cohorts via a seminar series and annual regional host-pathogen interactions symposium. The program builds on earlier phases in which the host-pathogen interactions community produced 106 publications in high-impact journals and secured more than $30 million in external NIH funding. The long-term goal is transition to a sustainable, well-organized academic center. Performance occurs in Grand Forks, North Dakota. The period of performance runs through March 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.1m | 7/30/26 |